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Abstract 
The prevalence of hyperuricemia in obese
children and adolescents and its association
with metabolic syndrome are largely unknown.
The objective of our study was to characterize
hyperuricemia  in  relation  to  metabolic  syn-
drome in Japanese children and adolescents
with obesity. Between 2005 and 2008, we per-
formed a cross-sectional study of 1,027 obese
children  and  adolescents  aged  6-14  years.
Based on the reference value of serum uric
acid  we  had  established  previously,  hyper-
uricemia was defined as one standard devia-
tion over the mean value at each age. The diag-
nosis of metabolic syndrome was made based
on the Japanese criteria for children. A total of
213  children  and  adolescents  (20.7%)  was
found to have hyperuricemia. The prevalence
of hyperuricemia was significantly higher in
the male gender and older age group. Sixty-five
out  of  213  subjects  with  hyperuricemia
(30.5%) had metabolic syndrome, whereas 111
out  of  814  subjects  without  hyperuricemia
(13.6%)  had  metabolic  syndrome.  The  most
common  abnormal  component  of  metabolic
syndrome  was  triglyceride,  followed  by  dia  -
stolic blood pressure, systolic blood pressure,
fasting  blood  glucose,  and  HDL-cholesterol.
Such a tendency was almost identical between
the two groups. We concluded that considering
the  association  between  hyperuricemia  and
metabolic syndrome in obese Japanese chil-
dren  and  adolescents,  the  role  of  hyper-
uricemia  in  metabolic  syndrome  should
receive  more  attention,  beginning  in  early
childhood.
Introduction
The prevalence of hyperuricemia in adults
has increased over the last several decades,
especially  in  developed  countries.
1 In
Japanese men, hyperuricemia is estimated to
have increased from 5% in the 1960s to 20%
in the 1990s.
2 Although the serum uric acid
(UA)  level  is  not  part  of  any  definition  of
metabolic  syndrome  (MetS),  a  number  of
studies  has  shown  strong  associations
between  UA  levels  and  MetS  or  its  compo-
nents.
3-7 For  example,  in  the  U.S.  National
Health  and  Nutrition  Examination  Survey
(NHANES)  of  1988-1994,  the  prevalence  of
MetS was found to increase substantially with
increasing levels of serum UA.
5 The pathogen-
esis of the link is not defined fully, but insulin
resistance is thought to play a pivotal role.
3
There is little information, however, on the
relationship  between  hyperuricemia  and
MetS  in  children  and  adolescents.  This  is
partly because of the difficulty of establishing
control or reference values for UA in children,
since UA values are highly dependent on age.
8
Furthermore,  unified  diagnostic  criteria  of
MetS for children have been established only
recently.
9,10 The aim of our present study was
to identify the association of hyperuricemia
and MetS in obese children and adolescents
based on our own reference value for UA and
the Japanese criteria for pediatric MetS.
Materials and Methods
Study population
We enrolled children and adolescents aged
6-14 years, who were diagnosed at a regular
school  examination  (height,  weight,  and
waist  circumstance)  in  Amagasaki  city
between 2005 and 2008 as being obese, and
who  subsequently  underwent  a  medical
examination.  The  medical  examination
included blood pressure (BP), and blood tests
at  a  fasting  condition  including  glucose,
triglyceride, HDL-cholesterol, and UA. Blood
pressure was measured with a mercury-grav-
ity manometer using the right arm of the sub-
jects who set in a relaxed position. The mean
of the duplicate measurements was taken as
the record of BP. Obesity was defined by the
obesity index ≥20% of that calculated by the
formula: (subject’s weight − standard weight)
÷ standard weight ×100.
11 Here, the standard
weight denotes the age–height-related stan-
dard of weight based on the 1990 school year
data of the Japanese Ministry of Education,
Culture, Sports, Science, and Technology.
11 UA
values were measured with a uricase kit (Ono
Pharmaceutical, Tokyo, Japan) using the uri-
case-peroxidase method.
12 We had previously
established  the  reference  value  of  UA  in
Japanese children at various ages.
8 Based on
the reference value of each age group, hyper-
uricemia was defined as exceeding the mean
plus one standard deviation. Namely, the cut-
off levels are 5.9 mg/dL for 6-8 years (both
genders), 6.1 mg/dL for 9-11 years (both gen-
ders),  7.0  mg/dL  (males),  and  6.2  mg/dL
(females) for 12-14 years. The diagnostic cri-
teria for MetS for Japanese children included
a waist circumstance ≥80 cm and/or a waist
circumference-to-height ratio ≥0.5 as a pre-
requisite. In addition, for positivity at least
two  of  the  following  three  components  are
necessary:  systolic  BP  ≥125  mmHg  and/or
diastolic BP ≥70 mmHg; HDL-cholesterol <40
mg/dL and/or triglyceride ≥120 mg/dL; blood
glucose ≥100 mg/dL.
10 A total of 1,027 children
and  adolescents  were  enrolled  finally,  after
excluding  those  with  incomplete  data  and
those already physician-diagnosed with type
II  diabetes  mellitus  or  hypertension.  Our
study was approved by the ethical committee
for  epidemiological  study  at  Nara  Women’s
University.
Statistics
Differences  in  the  prevalence  of  hyper-
uricemia  according  to  gender  and  age  were
examined by the Chi-square test and one-way
analysis of variance (ANOVA), respectively. In
MetS-positive  and  -negative  subjects  with
hyperuricemia,  differences  in  demographic
factors  and  components  of  MetS  were  also
determined  by  the  Chi-square  test.  Logistic
regression  analysis  was  performed  to  deter-
mine  the  association  between  presence  or
absence  of  hyperuricemia  and  demographic
factors or components of MetS. The statistical
analysis were done using “StatMate 3” (ATMS,
Tokyo, Japan). P<0.05 were considered signif-
icant.
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Results
Prevalence of hyperuricemia in
relation to age and gender
Age  and  gender  distributions  of  subjects
with hyperuricemia are summarized in Table
1. The total prevalence of hyperuricemia was
significantly  higher  (P<0.01)  in  males
(24.4%)  than  in  females  (15.2%).  Further  -
more, the percentages of subjects with hyper-
uricemia increased with age regardless of gen-
der  (P<0.001).  In  fact,  the  percentages  of
hyperuricemia were highest in the age group
of 12-14 years in both genders. 
Prevalence and components of
metabolic syndrome in subjects
with hyperuricemia
In total, 176 out of 1,027 subjects (17.1%)
met the diagnostic criteria for MetS (data not
shown). As shown in Table 2, 65 out of 213 sub-
jects with hyperuricemia (30.5%) had MetS.
There were no gender or age differences in the
frequency of MetS. The positivity of every com-
ponent of MetS was significantly higher in the
MetS-positive group. 
Association between hyperuricemia
and demographic factors or com-
ponents of metabolic syndrome
Logistic  regression  analysis  revealed  that
hyperuricemia  was  independently  associated
with male gender, older age, degree of obesity,
systolic BP, and HDL-cholesterol. On the other
hand, no association was found between hyper-
uricemia and waist circumference, diastolic BP,
triglyceride, or fasting blood glucose (Table 3).
Discussion
Recent studies have documented the associ-
ation among hyperuricemia, obesity, and MetS
in adults.
3-7 In particular, increased serum UA
levels are associated with a risk of cardiovas-
cular  disease  or  renal  disease.
13,14 Several
investigators have shown that insulin resist-
ance plays a central role in the link between
MetS  and  hyperuricemia.
3,15,16 Insulin  resist-
ance is thought to cause decreased excretion
of  UA.
17,18 Accordingly,  the  amelioration  of
insulin resistance by either a low-energy diet
or an insulin-sensitizing agent was found to
decrease serum UA levels.
19
There are several large-population studies
on the prevalence of MetS during childhood.
20,21
The reported rates differ widely; for example,
0.2-6.4%, depending on the study population
and the definition of MetS.
22-25 The prevalence
increased, range: 15.6% to 35.7%, when sub-
jects were restricted to obese children and ado-
lescents.
24,26-28 In NHANES III, for example, the 
prevalence of MetS in overweight adolescents
(body mass index [BMI] ≥95
th percentile) and
in adolescents at risk of being overweight (85
th
percentile ≤ BMI <95
th percentile) was 32.1%
and  7.1%,  respectively.
23 On  the  other  hand,
there is limited information about the associa-
tion  between  hyperuricemia  and  obesity  or
MetS in children and adolescents. In NHANES
(1999-2002), the prevalence of MetS increased
substantially along with the increase of serum
UA concentrations.
29 Using 120 obese children
in  the  United  States,  Pacifico  et  al. demon-
strated  an  independent  association  between
UA concentrations and the presence of MetS.
27
Notably, they have also shown that increased
UA levels are associated with carotid athero-
sclerosis. Such an association between hyper-
uricemia and components of MetS has been
seen in Asian countries.
30,31 Furthermore, lon-
gitudinal data from the Bogalusa Heart Study
indicated that obesity and MetS in childhood
were predictors of elevated UA in adulthood.
32
Another  Bogalusa  Heart  Study  demonstrated
that an elevated serum UA level is associated
with higher BP in childhood, which persists
into adulthood.
33
Most of the previous studies, however, have
used the criteria of MetS established for adults
with their own cut-off values. Therefore, in our
study we adopted the criteria of MetS recently
established  for  children  by  the  Japanese
Ministry of Health, Labor, and Welfare.
10 As for
defining hyperuricemia of childhood, we used
the reference values of UA in children at differ-
ent ages established by ourselves.
8 MetS was
found in 17.1% of a total population, which was
within the ranges of findings in previous stud-
ies, although the definition of MetS was differ-
ent.
24,26-28 On the other hand, the prevalence of
MetS  in  a  hyperuricemic  population  was
Article
Table 1. Number of subjects with hyperuricemia in relation to age and gender.
Gender Male Female Total
Age Total Hyperuricemia Total Hyperuricemia Total Hyperuricemia
6-8 yr 156 20 (12.8)* 122 8 (6.6) 278 28 (10.1)
9-11 yr 310 70 (22.6) 189 26 (13.8) 499 96 (19.2)
12-14 yr 154 61 (39.6) 96 28 (29.2) 250 89 (35.6)
Total 620 151 (24.4) 407 62 (15.2) 1027 213 (20.7)
*Numbers in parentheses indicate the percentage.
Table 2. Metabolic syndrome and its components in subjects with hyperuricemia.
Metabolic syndrome
Number (+) (-) P*
Total number (%) 213 65 (30.5)
§ 148 (69.5)
Gender  0.97
Male 151 (70.9) 46 (30.5) 105 (69.5)
Female 62 (29.1) 19 (30.6) 43 (69.4)
Age (year) (mean±s.d.) 11.0±1.9 11.2±2.0 10.9±2.1 0.33
Systolic blood pressure (SP) <0.001
<125 mmHg 164 (77.0) 36 (55.4) 128 (86.5)
≥125 mmHg  49 (23.0) 29 (44.6) 20 (13.5)
Diastolic blood pressure (DP) <0.001
<70 mmHg 120 (56.3) 10 (15.4) 110 (74.3)
≥70 mmHg  93 (43.7) 55 (84.6) 38 (25.7)
Blood pressure <0.001
SP<125 mmHg and DP<70 mmHg  99 (46.5) 4 (6.2) 95 (64.2)
SP≥125 mmHg and/or DP≥70 mmHg 114 (53.5) 61 (93.8) 53 (35.8)
HDL-cholesterol <0.01
≥40 mg/dL 174 (81.7) 46 (70.8) 128 (86.5)
<40 mg/dL  39 (18.3) 19 (29.2) 20 (13.5)
Triglyceride (TG) <0.001
<120 mg/dL 115 (54.0) 7 (10.8) 108 (73.0)
≥120 mg/dL 98 (46.0) 58 (89.2) 40 (27.0)
Lipids <0.001
HDL≥40 mg/dL and TG<120 mg/dL 109 (51.1) 4 (6.2) 105 (70.9)
HDL<40 mg/dL and/or TG≥120 mg/dL 104 (48.9) 61 (93.8) 43 (29.1)
Fasting blood glucose <0.001
<100 mg/dL 190 (89.2) 45 (69.2) 145 (98.0)
≥100 mg/dL  23 (10.8) 20 (30.8) 3 (2.0)
§Numbers in parentheses indicate the percentage; * c2 test.[page 40] [Pediatric Reports 2010; 2:e12]
30.1%;  almost  twice  that  in  a  non-hyper-
uricemic  population  (13.6%).  Among  the
demographic factors and components of MetS,
age, degree of obesity, systolic BP, and HDL-
cholesterol were significantly associated with
positivity  of  hyperuricemia.  However,  the
results of the association between UA levels
and each component of MetS were not consist  -
ent among studies, presumably owing to the
difference of ethnicity and cut-off values.
25-27,29
There are several limitations in our study.
First,  subjects  of  the  present  study  were
restricted to those with obesity. For the diagno-
sis of obesity, we used the obesity index com-
monly used in Japan instead of BMI.
11 The rea-
son is that the obesity index is thought to be
practical, as it does not need to take age-relat-
ed changes seen in the BMI standard for child-
hood  into  consideration.
34 Further  investiga-
tion on hyperuricemia and MetS in non-obese
children and adolescents is necessary. Second,
since this is a cross-sectional study, the rela-
tion of hyperuricemia to the future occurrence
of lifestyle-related disorders was not elucidat-
ed. Finally, information about the lifestyles of
the  subjects,  especially  diet,  is  lacking.  The
habit of frequently eating purine-rich food may
cause hyperuricemia and MetS simultaneous-
ly.
35 In spite of these limitations, the present
study  is,  as  far  as  we  know,  the  first  large
cohort study for delineating the association of
hyperuricemia and MetS in obese children and
adolescents  based  on  the  pediatric  criteria.
Considering the high prevalence of MetS in
hyperuricemic children and adolescents, pedi-
atricians  should  pay  more  attention  to  the
association between hyperuricemia and MetS.
Efforts  to  reduce  the  morbidity  of  hyper-
uricemia  through  the  management  of
lifestyles, especially in obese children, are ne  -
cessary.
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